trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'breast']
fam-trastuzumab deruxtecan-nxki doubles progression-free survival in her2-low metastatic breast cancer - the asco post 
Physician, Precision Oncology, Researcher,  Cancer Expert, CEO Protean Biodiagnostics. Professor Oncology and Pathology.